{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:03:53Z","timestamp":1773738233462,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alterations in specific DNA damage repair mechanisms in the presence of human papillomavirus (HPV) infection have been described in different experimental models. However, the global effect of HPV on the expression of genes involved in these pathways has not been analyzed in detail. In the present study, we compared the expression profile of 135 genes involved in DNA damage repair among primary human keratinocytes (PHK), HPV-positive (SiHa and HeLa) and HPV-negative (C33A) cervical cancer derived cell lines. We identified 9 genes which expression pattern distinguishes HPV-positive tumor cell lines from C33A. Moreover, we observed that Three Prime Repair Exonuclease 1 (TREX1) expression is upregulated exclusively in HPV-transformed cell lines and PHK expressing HPV16 E6 and E7 oncogenes. We demonstrated that TREX1 silencing greatly affects tumor cells clonogenic and anchorage independent growth potential. We showed that this effect is associated with p53 upregulation, accumulation of subG1 cells, and requires the expression of E7 from high-risk HPV types. Finally, we observed an increase in TREX1 levels in precancerous lesions, squamous carcinomas and adenocarcinomas clinical samples. Altogether, our results indicate that TREX1 upregulation is important for cervical tumor cells growth and may contribute with tumor establishment and progression.<\/jats:p>","DOI":"10.1038\/s41598-018-37064-x","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:32:59Z","timestamp":1548243179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo"],"prefix":"10.1038","volume":"9","author":[{"given":"Bruna","family":"Prati","sequence":"first","affiliation":[]},{"given":"Walason","family":"da Silva Abjaude","sequence":"additional","affiliation":[]},{"given":"Lara","family":"Termini","sequence":"additional","affiliation":[]},{"given":"Mirian","family":"Morale","sequence":"additional","affiliation":[]},{"given":"Suellen","family":"Herbster","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Rafaella Almeida Lima","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Lizeth Carolina","family":"C\u00f3rdoba Camacho","sequence":"additional","affiliation":[]},{"given":"Silvia Helena","family":"Rabelo-Santos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-0971","authenticated-orcid":false,"given":"Luiz Carlos","family":"Zeferino","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Aguayo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-0273","authenticated-orcid":false,"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"issue":"Suppl 1","key":"37064_CR1","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jcv.2004.12.006","volume":"32","author":"J Doorbar","year":"2005","unstructured":"Doorbar, J. The papillomavirus life cycle. J Clin Virol 32(Suppl 1), S7\u201315, https:\/\/doi.org\/10.1016\/j.jcv.2004.12.006 (2005).","journal-title":"J Clin Virol"},{"key":"37064_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2613.2001.00177.x","volume":"82","author":"HR McMurray","year":"2001","unstructured":"McMurray, H. R., Nguyen, D., Westbrook, T. F. & McAnce, D. J. Biology of human papillomaviruses. Int J Exp Pathol 82, 15\u201333 (2001).","journal-title":"Int J Exp Pathol"},{"key":"37064_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129\u20131136 (1990).","journal-title":"Cell"},{"key":"37064_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0092-8674(91)90529-8","volume":"67","author":"T Crook","year":"1991","unstructured":"Crook, T., Tidy, J. A. & Vousden, K. H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547\u2013556 (1991).","journal-title":"Cell"},{"key":"37064_CR5","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1002\/j.1460-2075.1992.tb05375.x","volume":"11","author":"MS Lechner","year":"1992","unstructured":"Lechner, M. S. et al. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11, 3045\u20133052 (1992).","journal-title":"EMBO J"},{"key":"37064_CR6","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1073\/pnas.90.9.3988","volume":"90","author":"TD Kessis","year":"1993","unstructured":"Kessis, T. D. et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90, 3988\u20133992 (1993).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37064_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.2537532","volume":"243","author":"N Dyson","year":"1989","unstructured":"Dyson, N., Howley, P. M., M\u00fcnger, K. & Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934\u2013937 (1989).","journal-title":"Science"},{"key":"37064_CR8","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/jvi.63.10.4417-4421.1989","volume":"63","author":"K M\u00fcnger","year":"1989","unstructured":"M\u00fcnger, K., Phelps, W. C., Bubb, V., Howley, P. M. & Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417\u20134421 (1989).","journal-title":"J Virol"},{"key":"37064_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/j.1460-2075.1990.tb08091.x","volume":"9","author":"MS Barbosa","year":"1990","unstructured":"Barbosa, M. S. et al. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J 9, 153\u2013160 (1990).","journal-title":"EMBO J"},{"key":"37064_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/viro.2001.1263","volume":"292","author":"L Sherman","year":"2002","unstructured":"Sherman, L. et al. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Virology 292, 309\u2013320, https:\/\/doi.org\/10.1006\/viro.2001.1263 (2002).","journal-title":"Virology"},{"key":"37064_CR11","first-page":"3837","volume":"61","author":"GS Akerman","year":"2001","unstructured":"Akerman, G. S. et al. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res 61, 3837\u20133843 (2001).","journal-title":"Cancer Res"},{"key":"37064_CR12","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.1073\/pnas.170093297","volume":"97","author":"S Duensing","year":"2000","unstructured":"Duensing, S. et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97, 10002\u201310007, https:\/\/doi.org\/10.1073\/pnas.170093297 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37064_CR13","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1128\/JVI.74.6.2679-2686.2000","volume":"74","author":"DA Francis","year":"2000","unstructured":"Francis, D. A., Schmid, S. I. & Howley, P. M. Repression of the integrated papillomavirus E6\/E7 promoter is required for growth suppression of cervical cancer cells. J Virol 74, 2679\u20132686 (2000).","journal-title":"J Virol"},{"key":"37064_CR14","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1128\/jvi.75.9.4283-4296.2001","volume":"75","author":"M Nees","year":"2001","unstructured":"Nees, M. et al. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol 75, 4283\u20134296, https:\/\/doi.org\/10.1128\/jvi.75.9.4283-4296.2001 (2001).","journal-title":"J Virol"},{"key":"37064_CR15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/JVI.72.2.1131-1137.1998","volume":"72","author":"JT Thomas","year":"1998","unstructured":"Thomas, J. T. & Laimins, L. A. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol 72, 1131\u20131137 (1998).","journal-title":"J Virol"},{"key":"37064_CR16","first-page":"3154","volume":"57","author":"II Wistuba","year":"1997","unstructured":"Wistuba, I. I. et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57, 3154\u20133158 (1997).","journal-title":"Cancer Res"},{"key":"37064_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-1-3","volume":"1","author":"H Arias-Pulido","year":"2002","unstructured":"Arias-Pulido, H., Narayan, G., Vargas, H., Mansukhani, M. & Murty, V. V. Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions. Mol Cancer 1, 3 (2002).","journal-title":"Mol Cancer"},{"key":"37064_CR18","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/sj.bjc.6602237","volume":"91","author":"W Alazawi","year":"2004","unstructured":"Alazawi, W. et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer 91, 2063\u20132070, https:\/\/doi.org\/10.1038\/sj.bjc.6602237 (2004).","journal-title":"Br J Cancer"},{"key":"37064_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-5","volume":"4","author":"PH Rao","year":"2004","unstructured":"Rao, P. H. et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4, 5, https:\/\/doi.org\/10.1186\/1471-2407-4-5 (2004).","journal-title":"BMC Cancer"},{"key":"37064_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/path.1966","volume":"209","author":"SM Wilting","year":"2006","unstructured":"Wilting, S. M. et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 209, 220\u2013230, https:\/\/doi.org\/10.1002\/path.1966 (2006).","journal-title":"J Pathol"},{"key":"37064_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-32","volume":"2","author":"SM Wilting","year":"2009","unstructured":"Wilting, S. M. et al. Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Med Genomics 2, 32, https:\/\/doi.org\/10.1186\/1755-8794-2-32 (2009).","journal-title":"BMC Med Genomics"},{"key":"37064_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2353\/jmoldx.2007.070007","volume":"9","author":"I Sokolova","year":"2007","unstructured":"Sokolova, I. et al. Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn 9, 604\u2013611, https:\/\/doi.org\/10.2353\/jmoldx.2007.070007 (2007).","journal-title":"J Mol Diagn"},{"key":"37064_CR23","first-page":"5465","volume":"55","author":"RD Steenbergen","year":"1995","unstructured":"Steenbergen, R. D. et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55, 5465\u20135471 (1995).","journal-title":"Cancer Res"},{"key":"37064_CR24","first-page":"2585","volume":"4","author":"P Cattani","year":"1998","unstructured":"Cattani, P. et al. Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 4, 2585\u20132589 (1998).","journal-title":"Clin Cancer Res"},{"key":"37064_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.qai.0000179460.61987.33","volume":"40","author":"SE Gagne","year":"2005","unstructured":"Gagne, S. E. et al. High-resolution analysis of genomic alterations and human papillomavirus integration in anal intraepithelial neoplasia. J Acquir Immune Defic Syndr 40, 182\u2013189 (2005).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"37064_CR26","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1038\/sj.onc.1203180","volume":"18","author":"O Rey","year":"1999","unstructured":"Rey, O., Lee, S. & Park, N. H. Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome. Oncogene 18, 6997\u20137001, https:\/\/doi.org\/10.1038\/sj.onc.1203180 (1999).","journal-title":"Oncogene"},{"key":"37064_CR27","doi-asserted-by":"publisher","first-page":"15038","DOI":"10.1073\/pnas.96.26.15038","volume":"96","author":"JP Therrien","year":"1999","unstructured":"Therrien, J. P., Drouin, R., Baril, C. & Drobetsky, E. A. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair. Proc Natl Acad Sci USA 96, 15038\u201315043 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37064_CR28","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1038\/sj.onc.1205762","volume":"21","author":"KS Srivenugopal","year":"2002","unstructured":"Srivenugopal, K. S. & Ali-Osman, F. The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein. Oncogene 21, 5940\u20135945, https:\/\/doi.org\/10.1038\/sj.onc.1205762 (2002).","journal-title":"Oncogene"},{"key":"37064_CR29","first-page":"209","volume":"28","author":"KH Shin","year":"2006","unstructured":"Shin, K. H. et al. HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways. Int J Oncol 28, 209\u2013215 (2006).","journal-title":"Int J Oncol"},{"key":"37064_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virusres.2006.06.011","volume":"122","author":"D Lembo","year":"2006","unstructured":"Lembo, D. et al. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage. Virus Res 122, 189\u2013193, https:\/\/doi.org\/10.1016\/j.virusres.2006.06.011 (2006).","journal-title":"Virus Res"},{"key":"37064_CR31","first-page":"7075","volume":"62","author":"S Duensing","year":"2002","unstructured":"Duensing, S. & M\u00fcnger, K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62, 7075\u20137082 (2002).","journal-title":"Cancer Res"},{"key":"37064_CR32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/JVI.72.1.749-757.1998","volume":"72","author":"RD Steenbergen","year":"1998","unstructured":"Steenbergen, R. D. et al. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes. J Virol 72, 749\u2013757 (1998).","journal-title":"J Virol"},{"key":"37064_CR33","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","volume":"131","author":"YG Yang","year":"2007","unstructured":"Yang, Y. G., Lindahl, T. & Barnes, D. E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131, 873\u2013886, https:\/\/doi.org\/10.1016\/j.cell.2007.10.017 (2007).","journal-title":"Cell"},{"key":"37064_CR34","doi-asserted-by":"publisher","first-page":"10163","DOI":"10.1158\/0008-5472.Can-07-2056","volume":"67","author":"Y Zhai","year":"2007","unstructured":"Zhai, Y. et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 67, 10163\u201310172, https:\/\/doi.org\/10.1158\/0008-5472.Can-07-2056 (2007).","journal-title":"Cancer Res"},{"key":"37064_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/gcc.20577","volume":"47","author":"L Scotto","year":"2008","unstructured":"Scotto, L. et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 47, 755\u2013765, https:\/\/doi.org\/10.1002\/gcc.20577 (2008).","journal-title":"Genes Chromosomes Cancer"},{"key":"37064_CR36","first-page":"1524","volume":"6","author":"A Manawapat-Klopfer","year":"2016","unstructured":"Manawapat-Klopfer, A. et al. TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions. Am J Cancer Res 6, 1524\u20131536 (2016).","journal-title":"Am J Cancer Res"},{"key":"37064_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13597","volume":"7","author":"R Wilson","year":"2016","unstructured":"Wilson, R. et al. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nat Commun 7, 13597, https:\/\/doi.org\/10.1038\/ncomms13597 (2016).","journal-title":"Nat Commun"},{"key":"37064_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674, https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"37064_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11010-013-1569-y","volume":"377","author":"D Bajpai","year":"2013","unstructured":"Bajpai, D., Banerjee, A., Pathak, S., Jain, S. K. & Singh, N. Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix. Mol Cell Biochem 377, 45\u201353, https:\/\/doi.org\/10.1007\/s11010-013-1569-y (2013).","journal-title":"Mol Cell Biochem"},{"key":"37064_CR40","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1073\/pnas.0806195105","volume":"105","author":"A Baldwin","year":"2008","unstructured":"Baldwin, A. et al. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci USA 105, 16478\u201316483, https:\/\/doi.org\/10.1073\/pnas.0806195105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37064_CR41","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.4161\/cc.7.12.6162","volume":"7","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh, D. et al. New roles for the major human 3\u2032-5\u2032 exonuclease TREX1 in human disease. Cell Cycle 7, 1718\u20131725, https:\/\/doi.org\/10.4161\/cc.7.12.6162 (2008).","journal-title":"Cell Cycle"},{"key":"37064_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1042\/bst0370535","volume":"37","author":"T Lindahl","year":"2009","unstructured":"Lindahl, T., Barnes, D. E., Yang, Y. G. & Robins, P. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease. Biochem Soc Trans 37, 535\u2013538, https:\/\/doi.org\/10.1042\/bst0370535 (2009).","journal-title":"Biochem Soc Trans"},{"key":"37064_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2006.06.005","volume":"23","author":"D Chowdhury","year":"2006","unstructured":"Chowdhury, D. et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 23, 133\u2013142, https:\/\/doi.org\/10.1016\/j.molcel.2006.06.005 (2006).","journal-title":"Mol Cell"},{"key":"37064_CR44","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1128\/mcb.24.15.6719-6727.2004","volume":"24","author":"M Morita","year":"2004","unstructured":"Morita, M. et al. Gene-targeted mice lacking the Trex1 (DNase III) 3\u2032\u2013 >5\u2032 DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 24, 6719\u20136727, https:\/\/doi.org\/10.1128\/mcb.24.15.6719-6727.2004 (2004).","journal-title":"Mol Cell Biol"},{"key":"37064_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ni.1941","volume":"11","author":"N Yan","year":"2010","unstructured":"Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 11, 1005\u20131013, https:\/\/doi.org\/10.1038\/ni.1941 (2010).","journal-title":"Nat Immunol"},{"key":"37064_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ni.2475","volume":"14","author":"M Hasan","year":"2013","unstructured":"Hasan, M. et al. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat Immunol 14, 61\u201371, https:\/\/doi.org\/10.1038\/ni.2475 (2013).","journal-title":"Nat Immunol"},{"key":"37064_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/carcin\/bgp333","volume":"31","author":"E Boccardo","year":"2010","unstructured":"Boccardo, E. et al. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha. Carcinogenesis 31, 521\u2013531, https:\/\/doi.org\/10.1093\/carcin\/bgp333 (2010).","journal-title":"Carcinogenesis"},{"key":"37064_CR48","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","volume":"12","author":"LV Ronco","year":"1998","unstructured":"Ronco, L. V., Karpova, A. Y., Vidal, M. & Howley, P. M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12, 2061\u20132072 (1998).","journal-title":"Genes Dev"},{"key":"37064_CR49","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.dnarep.2009.06.006","volume":"8","author":"CJ Wang","year":"2009","unstructured":"Wang, C. J., Lam, W., Bussom, S., Chang, H. M. & Cheng, Y. C. TREX1 acts in degrading damaged DNA from drug-treated tumor cells. DNA Repair (Amst) 8, 1179\u20131189, https:\/\/doi.org\/10.1016\/j.dnarep.2009.06.006 (2009).","journal-title":"DNA Repair (Amst)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37064-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:54:08Z","timestamp":1671252848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37064-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37064"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37064-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"11 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"351"}}